Number of pages: 100 | Report Format: PDF | Published date: 03 October, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
The global diabetic foot ulcer treatment market was pegged at US$ 3.54 billion in 2021 and is expected to witness a CAGR of 5.7% during the forecast period from 2022 to 2030.
Market Fundamentals
A diabetic foot ulcer is a common complication caused by diabetes mellitus. It is a skin sore wherein the skin tissue breaks down and can infect the surrounding tissue or even the bone. This kind of disease is growing rapidly due to the increasing number of diabetes patients, thus, greatly influencing the diabetic foot ulcer treatment market.
[7868534]
Market Dynamics
The global diabetic foot ulcer treatment market is an emerging industry and is expected to depict constant growth in the projected period. This growth can be attributed to the increasing prevalence of diabetes mellitus, which proportionately impacts the growth of diabetic foot ulcer conditions as complications of diabetes. Additionally, growing urbanization is also a significant cause for the rise in the obese population, poor health, lack of physical activities, and lack of proper diet among the population. Furthermore, technological advancements and increasing awareness about foot ulcer treatments further fuel the market expansion. However, the high cost of the diabetic foot ulcers treatment can prove to be major restraining factor in the market.
Market Ecosystem
The global diabetic foot ulcer treatment market has been analyzed from four perspectives: by type, treatment type, end-user, and region.
Diabetic Foot Ulcer Treatment Market by Type
Based on type, the global diabetic foot ulcer treatment market is segmented into ischemic ulcers, neuro-ischemic ulcers, and neuropathic ulcers. Neuro-ischemic ulcers hold the largest revenue share in the segment owing to a high prevalence of neuro-ischemic ulcers, thus, growth in the treatments. Furthermore, this type of foot ulcer has a considerable concern about infection, amputation, and could lead to fatality. While neuropathic ulcer holds the second largest revenue share with the growing cases of neuropathic diabetic foot ulcers.
Diabetic Foot Ulcer Treatment Market by Treatment Type
[65443243]
Based on the treatment type, the global diabetic foot ulcer treatment market is segmented into active therapies, wound care dressings, therapy devices, and others (photodynamic therapy, photo biomodulation, etc.). Wound care dressings dominate the market with the largest share in the segment. The growth of wound care dressings segment is attributed to high R&D activities and the continuous launch of new and innovative dressing products.
While therapy devices are an emerging segment at a significant rate and are estimated to show a noticeable growth during the forecast period. The therapy devices segment can further be classified as negative pressure wound therapy, ultrasound therapy, etc. Negative pressure wound therapy has gained much popularity in society. Furthermore, therapy devices provide a better recovery rate at an economical cost which can be easily affordable by economically low people. Additionally, technological advancement can provide optimal results, thereby encouraging the growth of this segment in the global diabetic foot ulcer treatment market.
Diabetic Foot Ulcer Treatment Market by End User
Based on end-user, the diabetic foot ulcer treatment market has been segmented into hospitals, clinics, ambulatory surgical centers, home care centers, and others. The hospital and clinics segment holds the largest revenue share in this market and is expected to show constant dominance in the forecast period. The dominance of the hospital segment is attributed to large patient footfall and the availability of enhanced technologies. Additionally, this segment has a high patient satisfaction rate. Also, it offers better reimbursement policies, thus, encouraging the growth of the market. While homecare centers, clinics, and ambulatory centers are expected to depict continuous development in the forecast period.
Diabetic Foot Ulcer Treatment Market by Region
Geographically, the global diabetic foot ulcer treatment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global diabetic foot ulcer treatment market with the largest revenue share. The rapid adoption of enhanced technologies, availability of developed healthcare infrastructure with significant healthcare expenditure, and large base of international market players contributes to the dominance of the diabetic foot ulcer treatment market in this region. Additionally, growing cases of diabetic foot ulcers because of increasing practice of sedentary lifestyle, physical inactivity, and a high population base for obese people, is fueling the development of the market.
Asia Pacific is also considered the fastest growing region in this market. This growth can be attributed to the rapid adoption of the latest technologies, development in the healthcare infrastructure, improving medical tourism, and increasing prevalence of diabetes mellitus.
Competitive Landscape
Some of the prominent players operating in the global diabetic foot ulcer treatment market are:
Strategic Developments
Report Attribute |
Details |
Market size value in 2021 |
US$ 3.54 billion |
Revenue forecast in 2030 |
US$ 5.83 billion |
Growth Rate |
CAGR of 5.7% from 2022 to 2030 |
Base year for estimation |
2021 |
Forecast period |
2022-2030 |
Segments covered |
By Type, Treatment Type, End-User, and Region. |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The growth of the diabetic foot ulcer treatment market is attributed to growing urbanization, increasing prevalence of diabetic foot ulcers, technological advancements in treatment techniques, and many more.
The Asia Pacific is estimated to experience rapid growth in the market during the projected period.
The diabetic foot ulcer treatment market is expected to grow at a CAGR of 5.7% in the forecast period from 2022 to 2030.
Top market players in diabetic foot ulcer treatment are Acelity L.P.Inc., Integra LifeSciences Corporation, B. Braun Melsungen AG, ConvaTec Group Plc., 3M Healthcare, Cardinal Health Inc., Smith & Nephew Plc., Tissue Regenix Group Plc., Mölnlycke Health Care AB, Coloplast Corp., Medline Industries Inc., and Medtronic Plc. among others.
*Insights on financial performance is subject to availability of information in public domain
Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities
GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach